• Mon news: Autolus enters CAR-T race with FDA approval. FDA clears clinical hold on Novavax. AbbVie schizophrenia trial failure. Cigna not pursuing Humana. GSK leaving BIO. See more on our front page

Byondis' breast cancer drug fails to bloom as FDA denies approval

cafead

Administrator
Staff member
  • cafead   May 16, 2023 at 10:32: PM
via Byondis' efforts to get an antibody-drug conjugate (ADC) treatment for HER-2 positive metastatic breast cancer have been pruned by the FDA.

article source